Advertisement

Topics

As mentioned earlier this week, Merck highlighted a STING abstract as one of their key ESMO presentations for next week. Guess we'll find out soon why it seems to be a talking point of theirs. https://twitter.com/ldtimmerman/status/1051235604501954560 

19:21 EDT 13 Oct 2018 | Brad Loncar

As mentioned earlier this week, Merck highlighted a STING abstract as one of their key ESMO presentations for next week. Guess we'll find out soon why it seems to be a talking point of theirs. https://twitter.com/ldtimmerman/status/1051235604501954560 …

Original Article: As mentioned earlier this week, Merck highlighted a STING abstract as one of their key ESMO presentations for next week. Guess we'll find out soon why it seems to be a talking point of theirs. https://twitter.com/ldtimmerman/status/1051235604501954560 

NEXT ARTICLE

More From BioPortfolio on "As mentioned earlier this week, Merck highlighted a STING abstract as one of their key ESMO presentations for next week. Guess we'll find out soon why it seems to be a talking point of theirs. https://twitter.com/ldtimmerman/status/1051235604501954560 "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...